Harbert Fund Advisors’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-2,725
Closed -$501K 114
2024
Q1
$501K Sell
2,725
-1,525
-36% -$290K 0.34% 76
2023
Q4
$764K Buy
+4,250
New +$662K 0.52% 52

Other funds holding RGEN

Harbert Fund Advisors's RGEN Position: Q2 2024 in Review

Harbert Fund Advisors sold out of Repligen (RGEN) in Q2 2024, closing a stake of 2,725 shares — an estimated $501K sold.

Harbert Fund Advisors first reported a position in RGEN in Q4 2023 and held it in 2 quarters. The position peaked at $764K in Q4 2023. 455 funds tracked by Wall St. Rank hold RGEN as of Q2 2024.

  • Harbert Fund Advisors reported no remaining Repligen position as of Q2 2024 after selling out during the quarter.
  • Harbert Fund Advisors sold 2,725 Repligen shares in Q2 2024, an estimated $501K.
  • Harbert Fund Advisors first reported a position in Repligen in Q4 2023 and held it in 2 quarters.
  • Harbert Fund Advisors's Repligen position peaked at $764K in Q4 2023.
  • 455 funds tracked by Wall St. Rank held Repligen as of Q2 2024.

Based on Harbert Fund Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.